Literature DB >> 18985357

Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.

Scott L Parker1, Frank J Attenello, Daniel M Sciubba, Giannina L Garces-Ambrossi, Edward Ahn, Jon Weingart, Benjamin Carson, George I Jallo.   

Abstract

BACKGROUND: Shunt infection is a morbid complication of CSF shunting. Though antibiotic-impregnated shunt (AIS) systems decrease shunt infections by preventing bacterial colonization following device implantation, their effectiveness in populations at high risk for infection has recently been disputed. We set out to determine whether the categorical switch to AIS systems at our institution has resulted in a decreased incidence of shunt infection in high-risk pediatric patients.
METHODS: We retrospectively reviewed the records from all pediatric patients undergoing CSF shunt procedures at The Johns Hopkins Hospital over a 10-year period between January 1997 and December 2007. During the 5.75 years prior to October 2002, all CSF shunts included standard, non-AIS catheters. During the 4.25 years after October 2002, all CSF shunts included AIS catheters. High-risk subgroups were defined a priori as prematurity (<35 weeks gestational age), shunts placed immediately post-meningitis, conversion of external ventricular drains (EVD) to shunt, and replacement of nosocomial shunt infection in patients requiring prolonged hospital stay (>1 month).
RESULTS: A total of 544 pediatric patients underwent 1,072 shunt placement procedures (502 AIS, 570 non-AIS). Of patients with non-AIS catheters, 64 (11.2%) experienced shunt infection, whereas only 16 (3.2%) patients with AIS catheters experienced shunt infection (p<0.001). AIS versus non-AIS was associated with decreased shunt infection in premature neonates [three (5.5%) vs. seven (20.0%), p=0.030], acutely following bacterial meningitis [two (5.7%) vs. nine (25.0%), p=0.043], when converting EVD to shunts [zero (0%) vs. four (13.3%), p=0.030], and in patients with prolonged hospital stay>1 month [three (5.3%) vs. 12 (18.5%), p=0.022]. Staphylococcus aureus was the most common infectious agent for both non-AIS (81.3%) and AIS (75.0%) systems.
CONCLUSION: The introduction of AIS catheters into our institutional practice has reduced the incidence of shunt infection in pediatric populations at highest risk for infection. AIS catheters are effective instruments to prevent peri-operative colonization of CSF shunt components.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18985357     DOI: 10.1007/s00381-008-0743-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  36 in total

1.  Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy.

Authors:  Munshi Moyenuddin; Christopher A Ohl; John C Williamson; James E Peacock
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

2.  Management of shunt infections: a multicenter pilot study.

Authors:  John R W Kestle; Hugh J L Garton; William E Whitehead; James M Drake; Abhaya V Kulkarni; D Douglas Cochrane; Cheryl Muszynski; Marion L Walker
Journal:  J Neurosurg       Date:  2006-09       Impact factor: 5.115

3.  The impact of antibiotic-impregnated catheters on shunt infection in children and neonates.

Authors:  Caroline Hayhurst; Richard Cooke; Dawn Williams; Jothy Kandasamy; Donncha F O'Brien; Conor L Mallucci
Journal:  Childs Nerv Syst       Date:  2007-10-26       Impact factor: 1.475

4.  A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections.

Authors:  W Kohnen; J Schäper; O Klein; B Tieke; B Jansen
Journal:  Zentralbl Bakteriol       Date:  1998-01

5.  Subcutaneous ventricular catheter reservoir and ventriculoperitoneal drain-related infections in preterm infants and young children.

Authors:  N Bruinsma; E E Stobberingh; M J Herpers; J S Vles; B J Weber; D A Gavilanes
Journal:  Clin Microbiol Infect       Date:  2000-04       Impact factor: 8.067

6.  In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections.

Authors:  J Hampl; J Schierholz; B Jansen; A Aschoff
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters.

Authors:  R A Kockro; J A Hampl; B Jansen; G Peters; M Scheihing; R Giacomelli; S Kunze; A Aschoff
Journal:  J Med Microbiol       Date:  2000-05       Impact factor: 2.472

8.  Repeat cerebrospinal fluid shunt infection in children.

Authors:  A V Kulkarni; D Rabin; M Lamberti-Pasculli; J M Drake
Journal:  Pediatr Neurosurg       Date:  2001-08       Impact factor: 1.162

9.  Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci.

Authors:  E A Gorzynski; D Amsterdam; T R Beam; C Rotstein
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  Infection of cerebrospinal fluid shunts in infants: a study of etiological factors.

Authors:  I K Pople; R Bayston; R D Hayward
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

View more
  18 in total

Review 1.  Strategies to decrease the risk of ventricular catheter infections: a review of the evidence.

Authors:  Maya A Babu; Robin Patel; W Richard Marsh; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

2.  Risk factors for surgical site infection following nonshunt pediatric neurosurgery: a review of 9296 procedures from a national database and comparison with a single-center experience.

Authors:  Brandon Sherrod; Anastasia Arynchyna; James Johnston; Curtis Rozzelle; Jeffrey Blount; W. Jerry Oakes; Brandon Rocque
Journal:  J Neurosurg Pediatr       Date:  2017-02-10       Impact factor: 2.375

3.  The use of the ASET in the diagnosis of ventriculoatrial shunt infection.

Authors:  Jacqueline Reaper; Sally Ann Collins; Roger Bayston
Journal:  BMJ Case Rep       Date:  2012-07-13

4.  The efficacy of silver-embedded polypropylene-grafted polyethylene glycol-coated ventricular catheters on prevention of shunt catheter infection in rats.

Authors:  Derya Burcu Hazer; Melike Mut; Nazmiye Dinçer; Zeynep Saribas; Baki Hazer; Tunçalp Ozgen
Journal:  Childs Nerv Syst       Date:  2012-02-29       Impact factor: 1.475

5.  Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants.

Authors:  Giovanni Raffa; Lucia Marseglia; Eloisa Gitto; Antonino Germanò
Journal:  Childs Nerv Syst       Date:  2015-03-28       Impact factor: 1.475

6.  Activity of an antimicrobial hydrocephalus shunt catheter against Propionibacterium acnes.

Authors:  Roger Bayston; Litza Vera; Waheed Ashraf
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

7.  Healthcare-associated bacterial meningitis.

Authors:  Sheethal Laxmi; Allan R Tunkel
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

8.  Evaluation of an in vivo model for ventricular shunt infection: a pilot study using a novel antimicrobial-loaded polymer.

Authors:  Rajiv R Iyer; Noah Gorelick; Karen Carroll; Ari M Blitz; Sarah Beck; Caroline M Garrett; Audrey Monroe; Betty Tyler; Sean T Zuckerman; Jeffrey R Capadona; Horst A von Recum; Mark G Luciano
Journal:  J Neurosurg       Date:  2018-08-03       Impact factor: 5.115

9.  Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures.

Authors:  Raquel Gutiérrez-González; Gregorio R Boto; Cristina Fernández-Pérez; Náyade del Prado
Journal:  BMC Neurol       Date:  2010-10-12       Impact factor: 2.474

10.  Shunt revision requirements after posthemorrhagic hydrocephalus of prematurity: insight into the time course of shunt dependency.

Authors:  Joanna Y Wang; Eric M Jackson; George I Jallo; Edward S Ahn
Journal:  Childs Nerv Syst       Date:  2015-08-07       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.